Atlas Trials

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Clinical trial NCT00125138 · COMPLETED

Trial details

NCT number
NCT00125138
Sponsor
Lundbeck LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's DiseasePsychotic Disorders
Start date
2005-07-01
Primary completion
2008-03-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.